Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


1.		Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				04U.115 NCT00429416


2.		Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				UPCC 20406 NCT00674427

Last Modified: 8/23/2008 First Published: 7/1/2001


3.		Phase II Pilot Study of High-Dose Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation and Immunotherapy With Activated T Cells, Interleukin-2, and Sargramostim (GM-CSF) in Patients With Stage IIIB or IV Breast Cancer or Other Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				WSU-2007-033 NCT00020722, RWMC-0634246

Last Modified: 9/3/2008 First Published: 2/14/2008


4.		Phase II Study of Conditioning Regimen Comprising Anti-thymocyte Globulin, Clofarabine, and Rituximab in Patients With Primary or Secondary Graft Failure After Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				NCI				UMN-2007LS072 UMN-2007LS072, UMN-MT2007-07, NCT00617929


5.		Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Other				06C.549 NCT00437372

Last Modified: 5/19/2008 First Published: 1/31/2008


6.		Phase I Study of Epstein-Barr Virus-Specific Cytotoxic T Lymphocytes in Patients Undergoing Mismatched-Related or Phenotypically Similar Unrelated Donor Marrow Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				Any age				Other				BCM-H-6676 H 6676, BCM-ETNA, NCT00608309

Last Modified: 8/23/2008 First Published: 2/10/2006


7.		Pilot Study of Aprepitant, Granisetron Hydrochloride, and Dexamethasone in Patients With Nausea and Vomiting Due to Therapy Comprising High Dose Cyclophosphamide Prior to Autologous Peripheral Blood Stem Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care, Treatment				Active				Over 18				NCI				WSU-D-2797 WSU-0504001728, NCT00293384

Select All on One Page